Key facts, as of
As of November 5, 2026, Humana Inc. (HUM) trades at $411.79, up 48.1% over the past year. Its 52-week range runs from $163.11 to $456.50; the price is 9.8% below that high. It is 27.9% below its all-time high of $571.30, reached in November 2022. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +163.1%, against +316.3% for the S&P 500 (SPY). It sits 32.6% above its 200-day average of $310.44, and its 50-day average is above the 200-day too: an uptrend on both averages. Its 30-day volatility is 48.3% annualized, which we rate high risk. It has a trailing P/E of 38.9 and a dividend yield of 0.85%. Humana Inc. (HUM) has confirmed its next earnings report for November 6, 2026, before the market opens (date from Yahoo Finance, listed on our November 2026 earnings calendar).
Cite: Portfolio Terminal, "Humana Inc. (HUM) stock analysis", 2026-11-05. https://portfolio-terminal.com/analyse/hum
Where it trades today
trading 85% of the way up its 52-week range
How the price has moved
How far it is from its record
Humana Inc. (HUM) is 27.9% below its all-time high of $571.30, reached in November 2022. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +163.1%, against +316.3% for the S&P 500 (SPY).
The read, from its own figures
What its numbers say
- HUM closes above its 50-day average ($402.84), and the 50-day sits above the 200-day ($310.44): on both averages the chart reads as an uptrend.
- At $417.42, HUM is 8.6% below its 1-year high of $456.50, set on October 9, 2026, and 155.9% above its 1-year low of $163.11 (March 20, 2026).
- Over the past month HUM rose 3.3%, from $404.27 to $417.42.
- HUM trades at 38.9x its last twelve months of earnings and 24.1x the next twelve months' estimate, so analysts expect earnings 61.5% higher.
- Its P/E is 112.2% above the 18.3x median of the 3 other healthcare plans companies we track (UNH, CVS, ELV).
- HUM's 30-day volatility, 48.3% a year, works out to a typical daily move of about 3.0%.
- Yahoo Finance puts its beta at 0.64: over five years of monthly returns, HUM moved about 0.64% for each 1% move of the S&P 500.
What would change the read
- A close under the 50-day average, $402.84 (−3.5% from the last close), would turn the read to a pullback; under the 200-day, $310.44 (−25.6%), the longer rise is in question.
- A close above $456.50 (+9.4%) would be a new 1-year high; below $163.11 (−60.9%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for HUM, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under healthcare plans among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for HUM by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for HUM. Last refresh: Nov 6, 2026, 1:52 AM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Healthcare Plans.
What Humana Inc. does
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit…
What analysts expect
HUM carries a buy consensus from 24 analysts, with an average price target of $465.13 versus $411.79 today (+13.0%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
HUM generated $145.68B in trailing revenue (26.2% year over year), with a 0.9% net margin, and $1.94B of free cash flow, supported by $9.13B of net cash.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $129.66B | — | — | $1.19B | $9.87 | $375.00M |
| 2024 | $117.76B | — | — | $1.21B | $10.01 | $2.39B |
| 2023 | $106.37B | — | — | $2.49B | $20.09 | $2.98B |
| 2022 | $92.87B | — | — | $2.81B | $22.20 | $3.45B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
HUM is in 17 of the 54 ETFs we track. It weighs most in XLV: 0.77% of the fund, holding #29 of 62.
Famous investors who hold it
HUM is in the latest 13F of 1 of the 15 famous investors we follow. George Soros (Soros Fund Management) holds the most of it: 0.16% of the portfolio, position #128 of 261, as of Q2 2026.
How its figures compare with those peers
Companies in the same industry
HUM beside the other companies Yahoo Finance files under healthcare plans among the assets we track (UNH, CVS, ELV, largest first).
HUMyou are here$411.79$49.45B
UNHUnitedHealth Group$395.72$354.57B
CVSCVS Health Corporation$81.33$104.06B
ELVElevance Health$432.00$93.69BWhat the chart is saying
In an uptrend, 8.6% under its 1-year high with no resistance above.
uptrend- Price is 3.6% above its 50-day average and 34.5% above its 200-day.
- RSI at 54 is neither stretched nor washed out.
- Nothing above has stopped it this year; the nearest floor is $414.01 (-0.8%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is HUM valued right now?
Humana Inc. trades at 38.9 times its last twelve months of earnings and 24.1 times the next twelve months' estimate (Yahoo Finance, November 5, 2026). On the chart: in an uptrend, 8.6% under its 1-year high with no resistance above. Price is 3.6% above its 50-day average and 34.5% above its 200-day.
What is the risk level of HUM?
Based on 30-day volatility of 48.3%, HUM has HIGH risk. Its beta of 0.64 means it has swung less than the S&P 500 over the last five years.
Does HUM pay dividends?
Yes, Humana Inc. has a dividend yield of 0.85%.
How far is HUM from its all-time high?
Humana Inc. is 27.9% below its all-time high of $571.30, reached in November 2022. Over the 10 years to the end of October 2026, with dividends reinvested, it returned +163.1%, against +316.3% for the S&P 500 (SPY).
When does Humana Inc. report earnings?
Humana Inc. (HUM) reports its next quarterly earnings on Friday, November 6, 2026, before the market opens. The company has confirmed the date; it comes from Yahoo Finance's earnings data and is listed on the Portfolio Terminal November 2026 earnings calendar. For that quarter, the analysts' consensus Yahoo Finance reports is a loss of $1.00 per share.
Which ETFs hold HUM?
17 of the 54 popular ETFs we track hold Humana Inc.. The largest weights: XLV (0.77%), VO (0.45%), JEPI (0.25%), RSP (0.21%) and VYM (0.19%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is HUM?
0.07%, as of September 30, 2026: HUM is holding #234 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.70 in Humana Inc..
Which famous investors own HUM?
George Soros (0.16% of Soros Fund Management's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for HUM?
The average analyst price target for Humana Inc. (HUM) is $465.13 based on 24 analyst estimates, about 13.0% above the current price of $411.79. The published range runs from $280.00 to $596.00.
How much revenue does HUM generate?
Humana Inc. reported $145.68B in trailing twelve-month revenue. Revenue growth is running at 26.2% year over year. Net margin sits at 0.9%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare HUM with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.